Adam S Grossman insider trades: Adma Biologics (ADMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adam reports to the SEC
Open-market buys and sales
58 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | ADMA | ↓ Sell10b5-1 | 147,000 | $12.00 | $1.8M | Direct | Nov 5, 2026 (0d) |
| Mar 16, 2026 | ADMA | ↓ Sell10b5-1 | 21,000 | $15.16 | $318K | Direct | Mar 17, 2026 (1d) |
| Feb 17, 2026 | ADMA | ↓ Sell10b5-1 | 21,000 | $16.08 | $338K | Direct | Feb 17, 2026 (0d) |
| Dec 15, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $19.79 | $416K | Direct | Dec 16, 2025 (1d) |
| Nov 19, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $16.00 | $336K | Direct | Nov 21, 2025 (2d) |
| Oct 24, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $16.00 | $336K | Direct | Oct 24, 2025 (0d) |
| Sep 15, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $16.13 | $339K | Direct | Sep 16, 2025 (1d) |
| Aug 15, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $16.88 | $354K | Direct | Aug 15, 2025 (0d) |
| Jul 15, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $18.66 | $392K | Direct | Jul 16, 2025 (1d) |
| Jun 16, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $20.81 | $437K | Direct | Jun 18, 2025 (2d) |
| May 15, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $19.45 | $408K | Direct | May 16, 2025 (1d) |
| Apr 15, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $21.46 | $451K | Direct | Apr 16, 2025 (1d) |
| Mar 19, 2025 | ADMA | ↓ Sell10b5-1 | 21,000 | $18.92 | $397K | Direct | Mar 21, 2025 (2d) |
| Nov 22, 2024 | ADMA | ↓ Sell | 48,967 | $21.10 | $1.0M | Direct | Nov 22, 2024 (0d) |
| Aug 27, 2024 | ADMA | ↓ Sell | 626,245 | $17.44 | $10.9M | Direct | Aug 27, 2024 (0d) |
| Jun 14, 2024 | ADMA | ↓ Sell | 100,000 | $10.72 | $1.1M | Direct | Jun 14, 2024 (0d) |
| Aug 18, 2023 | ADMA | ↓ Sell | 250,000 | $4.15 | $1.0M | Direct | Aug 18, 2023 (0d) |
| Aug 16, 2023 | ADMA | ↓ Sell | 510,472 | $4.54 | $2.3M | Direct | Aug 17, 2023 (1d) |
| Dec 9, 2022 | ADMA | ↑ Buy | 14,983 | $2.86 | $43K | Direct | Dec 9, 2022 (0d) |
| Dec 9, 2022 | ADMA | ↑ Buy | 14,982 | $2.86 | $43K | Indirect | Dec 9, 2022 (0d) |
| Oct 25, 2021 | ADMA | ↑ Buy | 250,000 | $1.00 | $250K | Indirect | Oct 26, 2021 (1d) |
| Oct 25, 2021 | ADMA | ↑ Buy | 100,000 | $1.00 | $100K | Direct | Oct 26, 2021 (1d) |
| Sep 8, 2020 | ADMA | ↑ Buy | 4,000 | $2.24 | $9K | Direct | Sep 10, 2020 (2d) |
| Aug 11, 2020 | ADMA | ↑ Buy | 6,000 | $3.04 | $18K | Direct | Aug 12, 2020 (1d) |
| Feb 11, 2020 | ADMA | ↑ Buy | 57,143 | $3.50 | $200K | Indirect | Feb 11, 2020 (0d) |
| Feb 11, 2020 | ADMA | ↑ Buy | 28,571 | $3.50 | $100K | Direct | Feb 11, 2020 (0d) |
| May 17, 2019 | ADMA | ↑ Buy | 25,000 | $4.00 | $100K | Indirect | May 21, 2019 (4d) |
| May 17, 2019 | ADMA | ↑ Buy | 5,000 | $4.00 | $20K | Direct | May 21, 2019 (4d) |
| Jun 8, 2018 | ADMA | ↑ Buy | 52,301 | $4.78 | $250K | Indirect | Jun 11, 2018 (3d) |
| Jun 8, 2018 | ADMA | ↑ Buy | 20,921 | $4.78 | $100K | Direct | Jun 11, 2018 (3d) |
| Nov 9, 2017 | ADMA | ↑ Buy | 485,000 | $2.15 | $1.0M | Indirect | Nov 13, 2017 (4d) |
| May 3, 2016 | ADMA | ↑ Buy | 200,000 | $6.50 | $1.3M | Indirect | May 5, 2016 (2d) |
| Dec 18, 2015 | ADMA | ↑ Buy | 6,400 | $8.47 | $54K | Indirect | Dec 22, 2015 (4d) |
| Dec 8, 2015 | ADMA | ↑ Buy | 500 | $9.00 | $5K | Direct | Dec 9, 2015 (1d) |
| Dec 2, 2015 | ADMA | ↑ Buy | 1,500 | $9.16 | $14K | Indirect | Dec 4, 2015 (2d) |
| Dec 2, 2015 | ADMA | ↑ Buy | 750 | $9.13 | $7K | Direct | Dec 4, 2015 (2d) |
| Dec 1, 2015 | ADMA | ↑ Buy | 1,800 | $9.17 | $17K | Indirect | Dec 3, 2015 (2d) |
| Nov 25, 2015 | ADMA | ↑ Buy | 1,800 | $9.18 | $17K | Indirect | Nov 30, 2015 (5d) |
| Nov 20, 2015 | ADMA | ↑ Buy | 3,500 | $9.22 | $32K | Indirect | Nov 23, 2015 (3d) |
| Nov 20, 2015 | ADMA | ↑ Buy | 361 | $9.12 | $3K | Direct | Nov 23, 2015 (3d) |
| Mar 19, 2015 | ADMA | ↑ Buy | 2,000 | $8.50 | $17K | Indirect | Mar 23, 2015 (4d) |
| Mar 17, 2015 | ADMA | ↑ Buy | 14,000 | $8.01 | $112K | Indirect | Mar 18, 2015 (1d) |
| Mar 16, 2015 | ADMA | ↑ Buy | 300 | $7.98 | $2K | By Child | Mar 18, 2015 (2d) |
| Mar 16, 2015 | ADMA | ↑ Buy | 300 | $7.98 | $2K | Direct | Mar 18, 2015 (2d) |
| Sep 12, 2014 | ADMA | ↑ Buy | 1,300 | $9.73 | $13K | Direct | Sep 15, 2014 (3d) |
| Sep 11, 2014 | ADMA | ↑ Buy | 3,000 | $9.50 | $29K | Indirect | Sep 15, 2014 (4d) |
| Aug 22, 2014 | ADMA | ↑ Buy | 1,000 | $9.50 | $10K | Indirect | Aug 26, 2014 (4d) |
| Aug 21, 2014 | ADMA | ↑ Buy | 600 | $9.50 | $6K | Indirect | Aug 25, 2014 (4d) |
| Aug 14, 2014 | ADMA | ↑ Buy | 2,100 | $9.77 | $21K | Indirect | Aug 15, 2014 (1d) |
| Jun 18, 2014 | ADMA | ↑ Buy | 1,875 | $9.59 | $18K | Indirect | Jun 20, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADMA insiders
Open-market trades in the last 12 months
About Adam S Grossman's insider trades
Adam S Grossman is President and CEO at Adma Biologics (ADMA). Since Oct 22, 2013, Adam has reported 40 open-market purchases worth $4.3M and 18 sales worth $22.7M on SEC Form 4. In the last 12 months: 5 sales ($3.2M).
13 sales (28% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (22 filings), grants and awards (17 filings), option exercises (16 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.